DSM-5

DSM-5

Pengarang	American Psychiatric Association
Negara	Amérika Serikat
Basa	Basa Inggris
Seri	Diagnostic and Statistical Manual of Mental Disorders
Subjek	Classification and diagnosis of mental disorders
Tanggal rilis	31UTCt
Jenis media	Print (hardcover, softcover); eBook
Kaca	947
ISBN	978-0-89042-554-1
Nomor OCLC	830807378
Desimal Dewey	616.89'075
Klasifikasi LC	RC455.2.C4
Didahului	DSM-IV-TR
Diikuti	DSM-5-TR
Text	[archive.org/details/diagnosticstatis0005unse DSM-5] online

Buku Panduan Diagnostik lan Statistik Gangguan Jiwa, Edisi Kelima ( DSM-5 ), inggih punika pembaruan warsa 2013 ring Buku Panduan Diagnostik lan Statistik Gangguan Jiwa, alat taksonomi lan diagnostik sane kamedalang olih Asosiasi Psikiatri Amerika (APA). Ring warsa 2022, sampun kamedalang versi sane sampun karevisi ( DSM-5-TR ). ^[1] Ring Amerika Serikat, DSM mawiguna pinaka otoritas utama antuk diagnosis psikiatri. ^[2] Rekomendasi pengobatan, taler pembayaran olih penyedia layanan kesehatan, sering katentuang olih klasifikasi DSM, dadosnyane penampakan versi anyar madue kepentingan praktis. Nanging, makudang-kudang penyedia gumanti ngandelang Klasifikasi Statistik Internasional Penyakit lan Masalah Kesehatan Terkait (ICD), ^[3] lan studi ilmiah sering ngukur pauwahan skor skala gejala bandingang pauwahan kriteria DSM-5 anggen nentuang efek dunia nyata saking intervensi kesehatan mental. ^{[4] [5] [6] [7]} DSM-5 inggih punika wantah asiki DSM sane nganggen angka Arab gumanti angka Romawi ring murdannyane, taler wantah asiki versi dokumen sane maurip saking DSM. ^[8]

DSM-5 nenten ja revisi sane ageng saking DSM-IV-TR, nanging makakalih madue pabinayan sane signifikan. Pauwahan ring DSM-5 minakadi re-konseptualisasi sindrom Asperger saking gangguan sane mabinayan dados gangguan spektrum autis ; sane ngicalang subtipe skizofrenia ; penghapusan "pengecualian berduka" antuk gangguan depresi ; ngalih wastan lan rekonseptualisasi gangguan identitas gender dados disforia gender ; ngranjingnyane gangguan makan binge pinaka gangguan makan sane diskrit; pangentos wastan lan rekonseptualisasi <i id="mwRw">parafilia</i>, sane mangkin kawastanin gangguan parafilia ; indik ngicalang sistem lima sumbu ; lan pemisahan gangguan sane nenten katentuang dados gangguan sane lianan sane sampun katentuang lan gangguan sane nenten katentuang .

Akeh para pejabat sane ngritik edisi kaping lima sadurung lan sesampun kamedalang. Para kritikus negesang, minakadi, akeh revisi utawi paweweh DSM-5 sane kirang madue dukungan empiris; indik reliabilitas antar rater sane kirang antuk akeh gangguan; indik makudang-kudang pahan madaging gatra sane kasurat kaon, ngawinang bingung, utawi matungkasan; lan indik industri farmasi minab sampun nenten patut ngawinang pengaruh ring daging manual, ngingetin asosiasi industri akeh pamilet kelompok kerja DSM-5. ^[9] APA punika sampun ngamedalang indik reliabilitas antar-rater sane kirang antuk akeh gangguan, rumasuk gangguan depresi mayor lan gangguan kecemasan umum. ^[10]

1. ↑ American Psychiatric Association, ed. (2022). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Washington, DC, USA: American Psychiatric Publishing. ISBN 978-0-89042-575-6.
2. ↑ Clark, Lee Anna; Cuthbert, Bruce; Lewis-Fernández, Roberto; Narrow, William E.; Reed, Geoffrey M. (2017). "Three Approaches to Understanding and Classifying Mental Disorder: ICD-11, DSM-5, and the National Institute of Mental Health's Research Domain Criteria (RDoC)". Psychological Science in the Public Interest. 18 (2): 72–145. doi:10.1177/1529100617727266. PMID 29211974. A survey of nearly 5,000 international psychiatrists ... [found that] DSM-IV use was nearly universal in the United States.
3. ↑ First, Michael B.; Rebello, Tahilia J.; Keeley, Jared W.; Bhargava, Rachna; Dai, Yunfei; Kulygina, Maya; Matsumoto, Chihiro; Robles, Rebeca; Stona, Anne-Claire; Reed, Geoffrey M. (June 2018). "Do mental health professionals use diagnostic classifications the way we think they do? A global survey". World Psychiatry. 17 (2): 187–195. doi:10.1002/wps.20525. PMC 5980454. PMID 29856559.
4. ↑ Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JP, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JP, Geddes JR (7 April 2018). "Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis". Lancet. 391 (10128): 1357–1366. doi:10.1016/S0140-6736(17)32802-7. PMC 5889788. PMID 29477251.
5. ↑ Bandelow B, Reitt M, Röver C, Michaelis S, Görlich Y, Wedekind D (July 2015). "Efficacy of treatments for anxiety disorders: a meta-analysis". International Clinical Psychopharmacology. 30 (4): 183–192. doi:10.1097/YIC.0000000000000078. PMID 25932596.
6. ↑ Schneider-Thoma J, Chalkou K, Dörries C, Bighelli I, Ceraso A, Huhn M, Siafis S, Davis JM, Cipriani A, Furukawa TA, Salanti G, Leucht S (26 February 2022). "Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis". Lancet. 399 (10327): 824–836. doi:10.1016/S0140-6736(21)01997-8. PMID 35219395 Check |pmid= value (help).
7. ↑ Gartlehner G, Crotty K, Kennedy S, Edlund MJ, Ali R, Siddiqui M, Fortman R, Wines R, Persad E, Viswanathan M (October 2021). "Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta-Analysis". CNS Drugs. 35 (10): 1053–1067. doi:10.1007/s40263-021-00855-4. PMC 8478737 Check |pmc= value (help). PMID 34495494 Check |pmid= value (help).
8. ↑ Wakefield, Jerome C. (2013-05-22). "DSM-5: An Overview of Changes and Controversies". Clinical Social Work Journal. 41 (2): 139–154. doi:10.1007/s10615-013-0445-2.
9. ↑ Welch, Steven; Klassen, Cherisse; Borisova, Oxana; Clothier, Holly (2013). "The DSM-5 controversies: How should psychologists respond?". Canadian Psychology. 54 (3): 166–175. doi:10.1037/a0033841.
10. ↑ Regier D, Narrow W, Clarke D, Kraemer H, Kuramoto S, Kuhl E, Kupfer D (2013). "DSM-5 Field Trials in the United States and Canada, Part II: Test-Retest Reliability of Selected Categorical Diagnoses". American Journal of Psychiatry. 170 (1): 59–70. doi:10.1176/appi.ajp.2012.12070999. PMID 23111466.